Today, we celebrate our incredible team at Veracyte! Your focus, expertise, and compassion make a meaningful difference in patients' lives every day. We're deeply grateful for how you embody our mission and your unwavering dedication to advancing cancer care. Want to recognize a colleague? Drop a shout-out in the comments below—today and every day is perfect for showing appreciation ?? #EmployeeAppreciationDay2025 #LifeAtVeracyte #HeartfeltThanks #CancerDiagnostics
Veracyte, Inc.
生物技术研究
South San Francisco,CA 21,966 位关注者
High-value insights, high-impact decisions
关于我们
Veracyte is a global diagnostics company that empowers clinicians with the high-value insights they need to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. Our growing menu of diagnostic tests answers important clinical questions to help patients avoid risky, costly procedures and interventions, and accelerate time to appropriate treatment.
- 网站
-
https://www.veracyte.com
Veracyte, Inc.的外部链接
- 所属行业
- 生物技术研究
- 规模
- 501-1,000 人
- 总部
- South San Francisco,CA
- 类型
- 上市公司
- 创立
- 2008
地点
Veracyte, Inc.员工
动态
-
?? Explore new data from ASCO #GU25 that shows?the power of the #Decipher tests to improve patient care and our GRID tool to advance prostate and bladder cancer research. “The breadth and depth of Decipher-focused data presented at the ASCO GU Symposium reinforce the widespread impact our Decipher tests are having on clinical care, as well as on research into the molecular underpinnings of prostate and bladder cancers,” said Elai Davicioni, Ph.D., Veracyte Medical Director for Urology. ?? Learn more at Veracyte.com - https://lnkd.in/dCm2NVFV #UrologicCancer #PrecisionMedicine?
-
-
?? Advancing urologic cancer care: We are excited to announce 17 Decipher-focused abstracts will be presented this week at the 2025 ASCO Genitourinary Cancers Symposium. These abstracts will highlight new data demonstrating how our market-leading Decipher tests continue to provide clinical utility in better informing treatment decisions for prostate and bladder cancer patients—helping drive innovation that will inform the future of urologic cancer care. Learn more about the new data on Decipher Prostate, Bladder, and GRID: https://lnkd.in/gvguhUMn ? #Decipher ##GU25 #UrologicCancer #PrecisionMedicine??
-
-
Today on World Cancer Day, we stand with millions of people worldwide in the fight against cancer. At Veracyte, our commitment to transform cancer care for patients all over the world runs deep. From expanding evidence for our high-performing tests to advancing global access, we strive to enable confident decision-making for patients and clinicians throughout their cancer diagnosis and treatment journey. These sample statistics underscore why our mission matters: ?? Prostate cancer ranks as the #1 diagnosed cancer in males across 66% of countries. (source: https://lnkd.in/gv6ZaMup) ?? Breast cancer affects 2.3M people annually as the world's most prevalent cancer. (source: https://lnkd.in/gUUZ6-GD) ?? Lung cancer claims 1.8M lives yearly - 19% of all cancer deaths. (source: https://lnkd.in/ghYajgjG) #WorldCancerDay #CancerAwareness #Innovation #Healthcare?
-
-
Veracyte welcomes the recent Le Monde article and stands with healthcare stakeholders advocating for equitable access to genomic testing and breast cancer care in France.????? Genomic tests like our Prosigna? Breast Cancer Assay help identify which patients truly need chemotherapy alongside hormone therapy. Studies show unnecessary chemotherapy can be spared, significantly improving quality of life while reducing side effects and treatment costs. ? ? Despite being reimbursed in many countries, genomic tests in France still lack full coverage, limiting their use and preventing access to personalized, less invasive treatment options for many women. It is time to close this gap and ensure equitable access to these innovative tools, paving the way for better patient outcomes and smarter healthcare investments. ?? Read more in Le Monde (French language article) on this issue: https://lnkd.in/dp_bF5YD #PrecisionMedicine #Prosigna #BreastCancer #GenomicTesting #Healthcare?
-
Today, we honor Dr. Martin Luther King Jr.'s powerful legacy of justice and equality, including his passionate advocacy for healthcare access for all. May his vision continue to drive meaningful change and progress in the world, ensuring medical breakthroughs in science reach every community through research, innovation, compassion, and care. ? ? #MLKDay #MLKDay2025 #healthcareequity #healthcareforall #socialjustice #innovation #unity
-
-
American Cancer Society’s annual report, Cancer Statistics, 2025, is now out and highlights encouraging progress that has been made in our fight against cancer as well as remaining challenges that persist, including rising incidences of breast cancer and prostate cancer and ongoing healthcare inequalities for underserved communities. Read ACS’s press release: https://lnkd.in/guHw4ShD If you are interested in learning more about Veracyte's tests, we invite you to visit: ???Prosigna Breast Cancer Assay: https://lnkd.in/g3Y4si-B ???Decipher Prostate Genomic Classifier: https://lnkd.in/gWUUSi9b #cancerresearch #cancerstatistics #researchmatters #cancerawareness? #fightcancer #oncology #breastcancer #prostatecancer #healthcareequality #genomictesting #moleculartesting #precisionmedicine?
-
?? We invite you to explore UroToday's Center of Excellence for Decipher Prostate. Leading experts in prostate cancer share their clinical experience with the test as well as their perspectives on the evolving landscape of genomic testing for #prostatecancer care. ?? Access the Decipher Prostate Center of Excellence on UroToday: https://lnkd.in/g47KNet2 #ProstateCancer #UrologyCare #GenomicTesting #PersonalizedMedicine #UroToday?
-
-
We’re pleased to announce Veracyte has been #GreatPlaceToWork – CertifiedTM in the US and Israel. We’re honored to receive this recognition, reflecting our collaborative culture driving our mission. Thank you for making us who we are #TeamVeracyte!? ? ??? Explore our Great Places to Work – Certified Company overview page: https://lnkd.in/gHVfSjpu?? ?? ??? Learn more about our exceptional team and working at Veracyte:?? https://lnkd.in/eiuur7cx?? ?? #GPTWcertified #employeeappreciation #workculture #lifeatVeracyte #employeeexperience #inspiredworkplace #pioneeringtogether #cultureofexcellence #workinIsrael #innovationculture #creativeecosystem #diverseworkplace??
-
-
From our #TeamVeracyte family to yours – thank you for making 2024 extraordinary! ?? To our incredible employees who fuel our progress, the physicians who trust our tests, and the partners who work with us to drive insights and evidence – thank you. Together we are transforming cancer care for patients around the world. ?? As we welcome 2025, we're grateful for each person who contributes to our mission of improving cancer care with exceptional diagnostics ?? Wishing you all moments of joy and meaningful connections this holiday season! #LifeSciences #Healthcare #Diagnostics?
-